Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues

Investigational New Drugs

Volumn 20, Issue 1, 2002, Pages 1-11

  Sakoff, Jennette A ^a   Ackland, Stephen P ^a   Baldwin, Monique L ^b   Keane, Mirella A ^b   McCluskey, Adam ^b  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Cantharidin; Cell cycle; Colon cancer; Fostriecin; PP1; PP2A

Indexed keywords

CANTHARIDIN; FOSTRIECIN; NORCANTHARIDIN; NOVO 1; NOVO 10; NOVO 2; NOVO 3; NOVO 4; NOVO 5; NOVO 6; NOVO 7; NOVO 8; NOVO 9; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CANTHARIDIN; CELL CYCLE; DNA; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; PHOSPHOPROTEIN PHOSPHATASE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0036208532     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014460818734     Document Type: Article

References (27)

1. Injuries from Coleoptera
2. Poisoning by cantharides
3. Cantharides intoxication
4. A fatal case of poisoning with cantharidin
5. Poisoning from "Spanish Fly"
6. Cantharidin poisoning associated with specific binding site in liver
7. Medical uses of mylabris in ancient China and recent studies
8. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells
9. Cantharidin-binding protein: Identification as protein phosphatase 2A
10. Renal toxicity of the anticancer drug fostriecin
11. Phase 1 and pharmacokinetic study of the topoisomerase II catalytic inhibitor
12. Serine/threonine protein phosphatases
13. The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis
14. Zinc inhibits apoptosis upstream of ICE/CED-9 proteases rather than at the level of an endonuclease
15. The intrinsic cell cycle: From yeast to mammals
16. Cdc 25 protein phosphatases in cell proliferation
17. 2 phase checkpoints
18. Cyclins and cyclin-dependent kinases: Theme and variations
19. Regulation of protein kinase cascades by protein phosphatase 2A
20. Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A
21. Okadaic acid, a potent inhibitor of type 1 and 2A protein phosphatases, activates cdc2/H1 kinase and transiently induces a premature mitosis-like state in BHK 21 cells
22. Inhibition of protein phosphatase 2A by cantharidin analogues
23. Anhydride modified Cantharidin analogues: Synthesis, anti-cancer activity and selective inhibition of protein phosphatase 1 and 2A
24. Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?
25. Thymidylate synthase inhibition induces S-phase arrest, biphasic mitochondrial alterations and caspase dependent apoptosis in leukaemia cells
26. Synergistic interaction between cisplatin and gemcitabine in vitro
27. Protein phosphatases and apoptosis: Protein phosphatases 1 and 2A, as potential components of cell death pathways in human cancer cell lines